Alumis (ALMS) Prepaid Assets (2024 - 2025)
Alumis (ALMS) reported Prepaid Assets of $3.9 million for Q1 2025, up 463.74% quarter-over-quarter from $695000.0 in Q4 2024.
Alumis (ALMS) Prepaid Assets (2024 - 2025) Analysis & Trends
Alumis (ALMS) has 2 years of Prepaid Assets data on file, last reported at $3.9 million in Q1 2025.
- Prepaid Assets for Q1 2025 came in at $3.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $3.9 million (changed N/A YoY), and the FY2024 annual result was $695000.0, changed N/A from the prior year.
- Prepaid Assets rose to $3.9 million in Q1 2025 per ALMS's latest filing, from $695000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $3.9 million in Q1 2025 and troughed at $695000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.92 Mn |
| Dec 31, 2024 | 695,000.00 |